Strategic Initiative

Slingshot members are tracking this corporate initiative:

Subsidiary of Valeant (VRX) and EyeGate (EYEG) Announce Exclusive Global Licensing Agreement for EGP-437 and EyeGate II Delivery System in Ocular Surgery

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VRX

100%
EYEG

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Feb 21, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Exclusive Global License Agreement, Egp-437, Eyegate Ii Delivery System, Ocular Surgery